Breast Cancer Breakthroughs Episode 14: Highlights from ASCO 2025 скачать в хорошем качестве

Breast Cancer Breakthroughs Episode 14: Highlights from ASCO 2025

The 2025 ASCO Annual Meeting brought together more than 40,000 doctors, scientists and patient advocates to discuss the latest advancements in cancer research. We saw big advancements across all stages and types of breast cancer and we’ll break them down in this episode of Breast Cancer Breakthroughs. You’ll hear from former Komen Scholar Dr. Dawn Hershman about the biggest news for early breast cancer. We’ll also discuss key takeaways on metastatic breast cancer and encourage you to check out our latest MBC Impact Series event, where we dive deeper into the advances in metastatic breast cancer and what they mean for patients. Kelsey Hampton, PhD, is Director, Mission Communications & Education at Susan G. Komen Dr. Dawn Hershman is a medical oncologist at Indiana University School of Medicine Sign up for reminders about future episodes of Breast Cancer Breakthroughs here: https://www.komen.org/about-komen/our... Link to Survey: https://susangkomen.iad1.qualtrics.co... Clinical Trial Finder: https://www.breastcancertrials.org/BC... Videos: BWEL trial:    • Breast Cancer Weight Loss (BWEL) Study   CompassHER2-pCR trial:    • Optimizing Therapy for HER2-Positive Breas...   Breast Cancer Breakthroughs Episode 13: Unlocking the Potential of Immunotherapy in TNBC: https://youtube.com/live/QQyIFGXqvVM?... MBC Impact Series: Best of ASCO 2025: The Importance of ESR1 mutations in metastatic breast cancer:    • Breast Cancer Breakthroughs: The Importanc...   Resources: Shining a Spotlight on the Unmet Needs of Patients with Advanced ER-positive/HER2-negative breast cancer: https://www.komen.org/blog/spotlight-... MBC Impact Series: https://www.komen.org/about-komen/our... Clinical Trials Mentioned in Episode: CHALLENGE (active, not recruiting): https://clinicaltrials.gov/study/NCT0... BWEL (active, not recruiting): https://clinicaltrials.gov/study/NCT0... CompassHER2pCR (active, not recruiting): https://clinicaltrials.gov/study/NCT0... OASIS-4 (active, not recruiting): https://www.clinicaltrials.gov/study/... VERITAC-2 (active, not recruiting): https://clinicaltrials.gov/study/NCT0... SERENA-6 (active, not recruiting): https://clinicaltrials.gov/study/NCT0... DESTINY-Breast09 (active, not recruiting): https://www.clinicaltrials.gov/study/... ASCENT-04 (active, not recruiting): https://clinicaltrials.gov/study/NCT0... 00:00 Introduction 00:51 Advances in Early Breast Cancer 03:29 Maximizing Treatment Benefit and Minimizing Toxicity 13:06 Advances in Metastatic Breast Cancer 17:18 Conclusion